COVID-19 Vaccine Update: COVAXIN Phase II/III Clinical Trails in Age Group of 2 to 18 Years to Begin in 10-12 Days
COVAXIN Phase II/III Clinical Trails in Age Group of 2 to 18 Years to Begin in 10-12 Days:
COVAXIN has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days: Dr. VK Paul, Member-Health, Niti Aayog #COVID19 pic.twitter.com/T0ITsJsixA
тАФ ANI (@ANI) May 18, 2021
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user’s social media account and Today News 24 Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of Today News 24, also Today News 24 does not assume any responsibility or liability for the same.)
